Lonza
Mark Holcroft is an experienced executive with a robust background in strategy, enterprise architecture, and digital transformation across various sectors. Currently serving as the Executive Director of Strategy and Enterprise Architecture at Lonza since November 2019, Mark leads data strategy and heads the Data Governance Board while driving digital transformation initiatives. Prior roles include Head of Strategy - CTO at Credit Suisse, where Mark aligned substantial resources for strategic execution, and Chief Technology Officer at Mundipharma IT Services, establishing key technological leadership. With a foundation in infrastructure management at Napp Pharmaceuticals Limited and a background in scientific research, Mark holds a BSc in Biological Chemistry from the University of Leicester and is currently pursuing education at Saïd Business School, University of Oxford.
This person is not in any teams
This person is not in any offices
Lonza
68 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.